[3 H]NAAG, N-acetyl-l-aspartyl-l-glutamic acid, has been widely used as a substrate in glutamate carboxypeptidase II (GCPII) reactions, either to determine the inhibitory constants at 50% inhibition (IC50 ) of novel compounds or to measure GCPII activities in different tissues harvested from various disease models. The importance of [3 H]NAAG, combined with its current commercial unavailability, prompted the development of a reliable eight-step synthetic procedure towards [3 H2 ]NAAG starting from commercially available pyroglutamate. Pure [3 H]NAAG of high molar activity (49.8 Ci/mmol) and desired stereochemistry was isolated in high radiochemical yield (67 mCi) and radiochemical purity (>99%). The identity was confirmed by mass spectrometry and co-injection with unlabeled reference.

Institute of Organic Chemistry and Biochemistry The Czech Academy of Sciences Prague Czech Republic

Zobrazit více v PubMed

Neale JH, Olszewski RT, Gehl LM, Wroblewska B, Bzdega T. The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia. Trends Pharmacol Sci. 2005;26(9):477-484. doi:10.1016/j.tips.2005.07.004

Neale JH, Bzdega T, Wroblewska B. N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J Neurochem. 2000;75(2):443-452. doi:10.1046/j.1471-4159.2000.0750443.x

Barinka C, Rojas C, Slusher B, Pomper M. Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer. Curr Med Chem. 2012;19(6):856-870. doi:10.2174/092986712799034888

Barinka C, Rinnová M, Šácha P, et al. Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II. J Neurochem. 2002;80(3):477-487. doi:10.1046/j.0022-3042.2001.00715.x

Paz MM, Sardina FJ. Enantiomerically pure dimethyl (2S)-7N-(9-phenylfluoren-9-yl)-3,4-didehydroglutamate as chiral educt. Chirospecific synthesis of (+)-5-O-carbamoylpolyoxamic acid and 3-alkylglutamates. J Org Chem. 1993;58(25):6990-6995. doi:10.1021/jo00077a015

Lee YJ, Park Y, Kim MH, Jew SS, Park HG. An enantioselective synthesis of (+)-polyoxamic acid via phase-transfer catalytic conjugate addition and asymmetric dihydroxylation. J Org Chem. 2011;76(2):740-743. doi:10.1021/jo102272h

Kadereit D, Deck P, Heinemann I, Waldmann H. Acid-labile protecting groups for the synthesis of lipidated peptides. Chem - A Eur J. 2001;7(6):1184-1193. doi:10.1002/1521-3765(20010316)7:6%3C1184::AID-CHEM1184%3E3.0.CO;2-5

Bergmeier SC, Cobás AA, Rapoport H. Chirospecific synthesis of (1S,3R)-1-amino-3-(hydroxymethyl)cyclopentane, precursor for carbocyclic nucleoside synthesis. Dieckmann cyclization with an α-amino acid. J Org Chem. 1993;58(9):2369-2376. doi:10.1021/jo00061a006

Oba M, Ohkuma K, Hitokawa H, Shirai A, Nishiyama K. Convenient synthesis of deuterated glutamic acid, proline and leucine via catalytic deuteration of unsaturated pyroglutamate derivatives. J Label Compd Radiopharm. 2006;49(3):229-235. doi:10.1002/jlcr.1038

Lockley WJS, Venanzi NAE, Crane GJ. Studies of hydrogen isotope scrambling during the dehalogenation of aromatic chloro-compounds with deuterium gas over palladium catalysts. J Label Compd Radiopharm. 2020;No. June(13):1-22. doi:10.1002/jlcr.3878

Valle MS, Retailleau P, Correia CRD. Synthesis of alexine-like compounds from chiral five-membered endocyclic enecarbamates. Tetrahedron Lett. 2008;49(12):1957-1960. doi:10.1016/j.tetlet.2008.01.098

Moody CM, Young DW. Investigation into direct use of protected 3,4-dehydropyroglutamates in synthesis. J Chem Res. 2005;2005(7):478-480. doi:10.3184/030823405774309087

Reich HJ, Wollowitz S. Preparation of α,β-unsaturated carbonyl compounds and nitriles by selenoxide elimination. In: Organic Reactions. John Wiley & Sons, Inc.; 1993:4-281. doi:10.1002/0471264180.or044.01.

Goebel-Stengel M, Stengel A, Taché Y, Reeve JR. The importance of using the optimal plasticware and glassware in studies involving peptides. Anal Biochem. 2011;414(1):38-46. doi:10.1016/j.ab.2011.02.009

Wolf JR. Review: self-radiolysis of compounds containing tritium and carbon-14. J Label Compd Radiopharm. 2021;64(8):286-335. doi:10.1002/jlcr.3903